好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Influence of Psycho-Stimulant Medication on Concussion Recovery in Athletes with ADHD: Findings from the NCAA-DOD Concussion Consortium
Neuro Trauma, Critical Care, and Sports Neurology
P2 - Poster Session 2 (11:45 AM-1:15 PM)
025

We sought to longitudinally evaluate concussion recovery in collegiate athletes with ADHD who were and were not taking psycho-stimulant medication.

Psycho-stimulant medication is commonly prescribed to individuals with ADHD. Some have posited that psycho-stimulant medications may mitigate impairments following sport-related concussion. However, no studies longitudinally evaluated the influence of psycho-stimulant medications on concussion recovery in collegiate athletes. 

Data from the NCAA-DOD Grand Alliance: Concussion Assessment, Research, and 好色先生 (CARE) Consortium were used to evaluate athletes with ADHD who were not taking psycho-stimulant medications (Rx-ADHD; n=20), athletes with ADHD who were taking psycho-stimulant medications (Rx+ADHD; n=20), and controls (n=80). Athletes with ADHD were double-matched to controls on biological sex, age, and body mass index. All athletes were assessed prior to their sporting season, 24-48 hours post-injury, and again upon unrestricted return-to-play (RTP). Cognition and clinical symptoms were evaluated using the ImPACT test. 

Athletes in the Rx-ADHD (10.4 ± 1.5 days) and Rx+ADHD (11.9 ± 1.7) groups exhibited prolonged symptom durations compared to controls (4.2 ± .8; p’s ≤ .05). Repeated-measures analyses of covariance (baseline scores = covariate) group × time interactions for multiple variables (p’s ≤.05). Univariate analyses revealed that both groups with ADHD demonstrated poorer verbal memory, and greater total symptoms at 24-48 hours post-injury than controls (p’s ≤ .01). Additionally, athletes in the Rx-ADHD group demonstrated poorer cognitive efficiency at 24-48 hours post-injury, and at RTP than controls (p’s ≤ .05). Lastly, athletes in the Rx+ADHD group demonstrated slower visual motor speed at 24-48 hours post-injury, and at RTP than controls (p’s ≤ .05).

Our findings suggest that following concussion athletes with ADHD may experience longer recovery than controls, regardless of medicated status. Interestingly, athletes with ADHD who were taking medication did not appear to have different recovery time relative to un-medicated athletes with ADHD.

Authors/Disclosures
Brett S. Gunn (University of South Carolina)
PRESENTER
Mr. Gunn has nothing to disclose.
Michael McCrea, PhD, ABPP (Medical College of Wisconsin) Dr. McCrea has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurotrauma Sciences. The institution of Dr. McCrea has received research support from NIH. The institution of Dr. McCrea has received research support from DoD. The institution of Dr. McCrea has received research support from NCAA. The institution of Dr. McCrea has received research support from NFL. The institution of Dr. McCrea has received research support from CDC. The institution of Dr. McCrea has received research support from Abbott Labs. Dr. McCrea has received publishing royalties from a publication relating to health care.
Steven Broglio, PhD (NeuroTrauma Research Laboratory) Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MCW. Dr. Broglio has received personal compensation in the range of $0-$499 for serving as a Consultant for U Calgary. Dr. Broglio has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Montgomery McCracken Walker & Rhoads LLP. The institution of Dr. Broglio has received research support from DoD. The institution of Dr. Broglio has received research support from NCAA.
R. Davis Moore, PhD (University of South Carolina) Dr. Moore has nothing to disclose.